Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride
2. Aricept
3. Donepezil
4. Donepezilium Oxalate Trihydrate
5. E 2020
6. E-2020
7. E2020
8. Eranz
1. 120011-70-3
2. Donepezil Hcl
3. Aricept
4. Bnag
5. 110119-84-1
6. 2-((1-benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1h-inden-1-one Hydrochloride
7. E2020
8. Donepezilhcl
9. E-2020
10. Aricept Odt
11. E 2020
12. Donepezil (hydrochloride)
13. Donepezil, Hcl
14. 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1h-inden-1-one Hydrochloride
15. Nsc-737535
16. Nsc-758882
17. Chembl1678
18. 3o2t2pj89d
19. 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;hydrochloride
20. 2-(1-benzyl-4-piperidylmethyl)-5,6-dimethoxy-1-indanone Hydrochloride
21. 120011-70-3 (hcl)
22. E2020;e-2020
23. Dsstox_cid_26698
24. Dsstox_rid_81832
25. Dsstox_gsid_46698
26. 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, Hydrochloride (1:1)
27. Eranz
28. 2-(1-benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one Hydrochloride
29. E 2020 (pharmaceutical)
30. Smr000449292
31. Cas-120011-70-3
32. Donepezil Hydrochloride [usan]
33. Nsc 737535
34. Nsc 758882
35. Ncgc00167537-01
36. Unii-3o2t2pj89d
37. Memorit
38. Memac
39. Aricept Evess
40. Donepezil,hcl
41. Aricept D
42. (+/-)-2-((1-benzyl-4-piperidyl)methyl)-5,6-dimethoxy-1-indanone Hydrochloride
43. (+/-)-2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone Hydrochloride
44. Aricept (tn)
45. Donepezil Hydrochloride [usan:usp]
46. Adlarity
47. Donepezil, Hydrochloride
48. 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hcl
49. Donepezil Hcl (aricept)
50. Donepezil Hcl - Bio-x
51. Schembl1815
52. Donepezil Hydrochloride,(s)
53. Mls000758276
54. Mls001401387
55. Chebi:4696
56. Dtxsid0046698
57. Pharmakon1600-01504403
58. Act02683
59. Amy40527
60. Bcp02205
61. Bcp24884
62. Hy-b0034
63. Donepezil Hydrochloride [mi]
64. Tox21_112534
65. Ac-913
66. Donepezil Hydrochloride (jp17/usp)
67. Donepezil Hydrochloride [jan]
68. Mfcd00881312
69. Nsc737535
70. Nsc758882
71. S2462
72. Akos000277343
73. Akos016340656
74. Tox21_112534_1
75. Ccg-101043
76. Ccg-213309
77. Cs-0863
78. Donepezil Hydrochloride [mart.]
79. Donepezil Hydrochloride [vandf]
80. Ks-1051
81. Nc00293
82. (+-)-2-((1-benzyl-4-piperidyl)methyl)-5,6-dimethoxy-1-indanone Hydrochloride
83. Donepezil Hydrochloride [usp-rs]
84. Donepezil Hydrochloride [who-dd]
85. Ncgc00167537-02
86. 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-, Hydrochloride
87. Bd164380
88. D4099
89. Donepezil Hydrochloride [orange Book]
90. Ft-0602354
91. Ft-0625589
92. Donepezil Hydrochloride [ep Monograph]
93. D00670
94. Donepezil Hydrochloride [usp Monograph]
95. E-2022
96. Namzaric Component Donepezil Hydrochloride
97. 119d841
98. A804411
99. Donepezil Hydrochloride Component Of Namzaric
100. Donepezil Hydrochloride Monohydrate, >=98% (hplc)
101. Q-100096
102. Q-201040
103. Q27106438
104. Donepezil Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
105. 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-1h-inden-1-one Hcl
106. 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]-1h-inden-1-one
107. (+-)-2,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1h-inden-1-one Hydrochloride
108. 2-((1-benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1h-inden-1-one Hydrochloride 120014-06-
Molecular Weight | 416.0 g/mol |
---|---|
Molecular Formula | C24H30ClNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 415.1914215 g/mol |
Monoisotopic Mass | 415.1914215 g/mol |
Topological Polar Surface Area | 38.8 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 510 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Aricept |
PubMed Health | Donepezil (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | ARICEPT (donepezil hydrochloride) is a reversible inhibitor of the enzyme acetylcholinesterase, known chemically as ()-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride. Donepezil hydrochloride is c... |
Active Ingredient | Donepezil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 5mg; 23mg; 10mg |
Market Status | Prescription |
Company | Eisai |
2 of 4 | |
---|---|
Drug Name | Donepezil hydrochloride |
Drug Label | Donepezil hydrochloride is a reversible inhibitor of the enzyme acetylcholinesterase, known chemically as ()-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride. Donepezil hydrochloride is commonly refe... |
Active Ingredient | Donepezil hydrochloride |
Dosage Form | Tablet, orally disintegrating; Tablet |
Route | oral; Oral |
Strength | 5mg; 23mg; 10mg |
Market Status | Tentative Approval; Prescription |
Company | Wockhardt; Mylan Pharms; Ranbaxy; Macleods Pharms; Jubilant Generics; Vivimed Labs; Teva; Apotex; Aurobindo; Indicus Pharma; Alembic Pharms; Cspc Ouyi Pharm; Sun Pharm Inds; Pliva Hrvatska Doo; Torrent Pharms; Zydus Pharms Usa; Dr Reddys Labs; Sandoz; Pri |
3 of 4 | |
---|---|
Drug Name | Aricept |
PubMed Health | Donepezil (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | ARICEPT (donepezil hydrochloride) is a reversible inhibitor of the enzyme acetylcholinesterase, known chemically as ()-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride. Donepezil hydrochloride is c... |
Active Ingredient | Donepezil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 5mg; 23mg; 10mg |
Market Status | Prescription |
Company | Eisai |
4 of 4 | |
---|---|
Drug Name | Donepezil hydrochloride |
Drug Label | Donepezil hydrochloride is a reversible inhibitor of the enzyme acetylcholinesterase, known chemically as ()-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride. Donepezil hydrochloride is commonly refe... |
Active Ingredient | Donepezil hydrochloride |
Dosage Form | Tablet, orally disintegrating; Tablet |
Route | oral; Oral |
Strength | 5mg; 23mg; 10mg |
Market Status | Tentative Approval; Prescription |
Company | Wockhardt; Mylan Pharms; Ranbaxy; Macleods Pharms; Jubilant Generics; Vivimed Labs; Teva; Apotex; Aurobindo; Indicus Pharma; Alembic Pharms; Cspc Ouyi Pharm; Sun Pharm Inds; Pliva Hrvatska Doo; Torrent Pharms; Zydus Pharms Usa; Dr Reddys Labs; Sandoz; Pri |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® HML C2910
Application : Coating Systems & Additives
Excipient Details : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.
Ingredient(s) : Hypromellose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® LCM 80.m
Application : Granulation
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 101
Application : Granulation
Excipient Details : Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 102
Application : Direct Compression
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Topical, Oral
Brand Name : Microlex® MLP 520
Application : Fillers, Diluents & Binders
Excipient Details : Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Available in different particle size as 25.µ, 50.µ, 180.µ
Ingredient(s) : Mannitol
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Meets Kosher and Halal preparations in Jewish and Arab cultures. Qualified in high specification standards requested by European formulators.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Dosage Form : Tablet
Grade : Oral
Brand Name : Sodium Stearyl Fumarate
Application : Lubricants & Glidants
Pharmacopoeia Ref : IP/BP/USP
Technical Specs : NA
Ingredient(s) : Sodium Stearyl Fumarate Excipient
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
84
PharmaCompass offers a list of Donepezil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Donepezil manufacturer or Donepezil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Donepezil manufacturer or Donepezil supplier.
PharmaCompass also assists you with knowing the Donepezil API Price utilized in the formulation of products. Donepezil API Price is not always fixed or binding as the Donepezil Price is obtained through a variety of data sources. The Donepezil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NAMZARIC manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NAMZARIC, including repackagers and relabelers. The FDA regulates NAMZARIC manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NAMZARIC API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NAMZARIC manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NAMZARIC supplier is an individual or a company that provides NAMZARIC active pharmaceutical ingredient (API) or NAMZARIC finished formulations upon request. The NAMZARIC suppliers may include NAMZARIC API manufacturers, exporters, distributors and traders.
click here to find a list of NAMZARIC suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NAMZARIC DMF (Drug Master File) is a document detailing the whole manufacturing process of NAMZARIC active pharmaceutical ingredient (API) in detail. Different forms of NAMZARIC DMFs exist exist since differing nations have different regulations, such as NAMZARIC USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NAMZARIC DMF submitted to regulatory agencies in the US is known as a USDMF. NAMZARIC USDMF includes data on NAMZARIC's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NAMZARIC USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NAMZARIC suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The NAMZARIC Drug Master File in Japan (NAMZARIC JDMF) empowers NAMZARIC API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the NAMZARIC JDMF during the approval evaluation for pharmaceutical products. At the time of NAMZARIC JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of NAMZARIC suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NAMZARIC Drug Master File in Korea (NAMZARIC KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NAMZARIC. The MFDS reviews the NAMZARIC KDMF as part of the drug registration process and uses the information provided in the NAMZARIC KDMF to evaluate the safety and efficacy of the drug.
After submitting a NAMZARIC KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NAMZARIC API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NAMZARIC suppliers with KDMF on PharmaCompass.
A NAMZARIC CEP of the European Pharmacopoeia monograph is often referred to as a NAMZARIC Certificate of Suitability (COS). The purpose of a NAMZARIC CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NAMZARIC EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NAMZARIC to their clients by showing that a NAMZARIC CEP has been issued for it. The manufacturer submits a NAMZARIC CEP (COS) as part of the market authorization procedure, and it takes on the role of a NAMZARIC CEP holder for the record. Additionally, the data presented in the NAMZARIC CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NAMZARIC DMF.
A NAMZARIC CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NAMZARIC CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NAMZARIC suppliers with CEP (COS) on PharmaCompass.
A NAMZARIC written confirmation (NAMZARIC WC) is an official document issued by a regulatory agency to a NAMZARIC manufacturer, verifying that the manufacturing facility of a NAMZARIC active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NAMZARIC APIs or NAMZARIC finished pharmaceutical products to another nation, regulatory agencies frequently require a NAMZARIC WC (written confirmation) as part of the regulatory process.
click here to find a list of NAMZARIC suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NAMZARIC as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NAMZARIC API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NAMZARIC as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NAMZARIC and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NAMZARIC NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NAMZARIC suppliers with NDC on PharmaCompass.
NAMZARIC Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NAMZARIC GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NAMZARIC GMP manufacturer or NAMZARIC GMP API supplier for your needs.
A NAMZARIC CoA (Certificate of Analysis) is a formal document that attests to NAMZARIC's compliance with NAMZARIC specifications and serves as a tool for batch-level quality control.
NAMZARIC CoA mostly includes findings from lab analyses of a specific batch. For each NAMZARIC CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NAMZARIC may be tested according to a variety of international standards, such as European Pharmacopoeia (NAMZARIC EP), NAMZARIC JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NAMZARIC USP).